A Study to Investigate the Relative Bioavailability of Entrectinib Capsule Formulations F1 and F06 Under Fed Conditions in Healthy Participants
Clinical trial NCT03796260 · COMPLETED
Trial details
- NCT number
- NCT03796260
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-09
- Primary completion
- 2019-02-04
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.